9. Kuopio Alzheimer Symposium ja 3. Nordic Me
International, scientific hybrid (on-line and live participation possibility ) congress focusing on neurodegenerative disorders, especially memory disorders. The presentations will be held in English.
The event is targeted for the clinicians, nurses, psychologists, scientists, students or other professionals who focus in their work on memory disorders. This educational event was also planned to fulfill the aims of theoretical studies for PhD program, specialization for clinicians and, for specialists that aim to apply special competence in memory disorders.
The presentations are given by the experts working in this field. The topics are focused on new insights of genetics, pathophysiology, preventive strategies, diagnostic methods and therapeutic interventions of neurodegenerative disorders. Also a model of multidisciplinary memory polyclinc work to detect memory disorders at their early stages is presented.
Kansainvälinen tieteellinen koulutus, joka syventää osaamista laaja-alaisesti muistisairauksista: preventiosta, patofysiologiasta ja muistisairauksien taustasyistä, diagnostiikasta , hoidosta ja hoitopoluista sekä monialaisesta ammatillisesta yhteistyöstä muistipoliklinikoilla. Koulutuksessa pureudutaan erityisesti uusiin mahdollisuuksiin tunnistaa muistisairaus varhemmin ja uusiin tutkimuslöydöksiin.
Koulutus soveltuu erityisesti lääkäreiden erikoistumiskoulutuksen osaksi, muistisairaiden parissa työskenteleville hoitajille, lääkäreille ja psykologeille tai muille ammattilaisille täydennyskoulutukseksi, luetaan hyväksi muistisairauksien erityispätevyys koulutukseen (lääkärit), alan väitöskirjatutkijoiden teoreettiseksi koulutukseksi (biolääketiede, lääketiede, hoitotieteet, psykologia ja muut tutkijat, jotka tekevät väitöskirjatyötä muistisairauksista).
Koulutusmuotoina ovat korkeatasoiset tieteelliset luennot ja paneelikeskustelut. Osallistujille on mahdollistetaan aktiivinen osallistuminen keskusteluun asiantuntijoiden kanssa (paikanpäällä oleville on varattu aikaa kysymyksiin, heille ja on-line osallistujille myös chat mahdollisuus)
Tilaisuus järjestetään ns. hybridimuotoisena (mahdollisuus osallistua paikanpäällä ja on-line)
Tilaisuuden ohjelma
9th Kuopio Alzheimer Symposium and 3rd Nordic Memory Clinic Conference
August 23–25, 2022
Day 1 – Tuesday, 23.8.2022:
3rd Nordic Memory Clinic Conference – NMCC
Opening of the 3rd Nordic Memory Clinic Conference and Session I: Advances in Alzheimer’s disease
Time slot Session title
09.00–9.10 Welcome
Anne Koivisto, Chairperson of the local NMCC Organising Committee and Jon Snaedal, Chair, Nordic Network in Dementia Diagnostics
09.10–9.25 Opening words
Sirpa Pietikäinen, Member of the European Parliament, Member of the Board of Alzheimer Europe
09.25–9.50 New perspectives on the pathogenesis of AD
Heikki Tanila, University of Eastern Finland, Kuopio, Finland
09.50–10.20 Q-EEG as novel technique in prognosis and differential diagnostic of cognitive impairment
Knut Engedal, University of Oslo, Norway
10.20–10.50 Structural Imaging - MRI new techniques
Lars-Olof Wahlund, Karolinska Institutet, Sweden
10.50–11.20 Treatment possibilities in next five-ten years: How we have to prepare for that at the clinics?
Jon Snaedal, National University Hospital of Iceland, Iceland
11.20–11.30 Discussion
Anne Koivisto and Jon Snaedal
11.30–12.30 Lunch, exhibition
Session II: Synucleinopathies: Where are we going?
Time slot Session title
12.30–13.00 Progression patterns of alpha-synuclein pathology
Liisa Myllykangas, University of Helsinki, Finland
13.00–13.30 Parkinson’s Disease related cognitive impairment
Dag Årsland, King’s College London, UK and University of Stavanger, Norway
13.30–14.00 Pharmacological treatment in LBD - new perspectives
John O’Brien, University of Cambridge, UK
14.00–14.30 Fecal microbiota transplantation as a treatment possibility in synucleinopathies and other neurodegenerative diseases
Filip Scheperjans, University of Helsinki, Finland
14.30–15.00 Coffee and tea break
Session III: Multidisciplinary Memory disorder meeting at Clinic: Two cases with neuropsychiatric symptoms on stage
Time slot Session title
15.00–15.20 Introduction of the cases with neuropsychiatric symptoms and cognitive deterioration
Chairpersons: Johanna Krüger and Peter Høgh
15.20–16.15 Topics to be discussed/presented by multidisciplinary team:
• Social background, environmental factors, FBI-Mod/NPI interview results
• Neurobiology behind neuropsychiatric symptoms
• Fluid and structural biomarkers of neurodegenerative disorders in differential diagnostics: Good or not good?
16.15–16.25 Conclusions - Behavioral FTD, AD, VCI or something else? Which features support the diagnosis?
Chairperson Johanna Krüger
16.25–16.50 Treatments of frontal symptoms in memory disorders
Risto Vataja, University of Helsinki, Finland
16.50–17.00 Closing of the day
Johanna Krüger, Anne Koivisto
17.15–19.15 Patient and Public Involvement (PPI) in Brain Disorders Satellite meeting
Target group: Researchers, clinicians, health care personnel, and students interested in PPI activities
17.15–17.20 Welcome and introduction
Anna Mäki-Petäjä-Leinonen, University of Eastern Finland, Finland
17.20–17.30 Personalized medicine approach for novel microglia-associated genetic variants in Alzheimer’s disease (PMG-AD)
Mikko Hiltunen, University of Eastern Finland, Finland
17.30–17.40 Evaluating the contribution of biological age in the risk of progressing to dementia (PreADAPT)
Alfredo Ramirez, University of Cologne, Germany
17.40–17.50 Prediagnostic early synaptic disturbances in neurodegenerative diseases (SynaDeg)
Annakaisa Haapasalo, University of Eastern Finland, Finland
17.50–18.00 Patient Advisory board’s contribution to the EU-FINGERS project
Anna Rosenberg, Finnish Institute of Health and Welfare and Karolinska Institutet, Sweden
18.00–18.20 Organizing co-research teams: going beyond frameworks and guidelines. Lessons from the practice
Päivi Eriksson and Caterina Bettin, University of Eastern Finland, Kuopio, Finland
18.20–18.40 Tips and advice on how to conduct PPI in the context of research projects related to dementia
Ana Diaz, Alzheimer Europe Project Officer, Luxembourg
18.40–19.10 Round table discussion
19.10–19.15 Closing
20.00–22.00 Welcome reception
Day 2 – Wednesday 24.8.2022
• Opening day of the 9th Kuopio Alzheimer Symposium
• Second day of the 3rd Nordic Memory Clinic Conference – NMCC
9th Kuopio Alzheimer Symposium
Opening of the 9th Kuopio Alzheimer Symposium and Keynote session
Time slot Session title
09.00–09.05 Opening words
Mikko Hiltunen, University of Eastern Finland, Finland, Chair of the Organizing Committee
09.05–09.15 Welcome address
Jussi Pihlajamäki, Dean of the Faculty of Health Sciences, University of Eastern Finland, Finland
09.15–09.30 Welcome address
Philippe Amouyel, University Hospital of Lille, France
09.30–09.45 Address from the expert by experience
09.45–10.30 Keynote lecture: The Alzheimer Landscape in 2022 and beyond
Philip Scheltens, VUMC Amsterdam, Netherlands
10.30–11.00 Coffee and tea break, exhibition, and posters (odd numbers)
Oral session I: Genetics and personalized medicine in neurodegenerative diseases
Time slot Session title
11.00–11.25 New insights on the genetic etiology of Alzheimer’s and related dementia
Jean-Charles Lambert, INSERM/Institut Pasteur Lille, France
11.25–11.50 Outcomes of the genome-wide genetic analyses in MCI
Alfredo Ramirez, University of Cologne, Germany
11.50–12.15 Cholesterol and matrisome pathways dysregulated in APOE ε4 human astrocytes
Julia TCW, Boston University School of Medicine, Boston, MA, USA
12.15–12.40 Mechanistic elucidation of Alzheimer’s disease using iPSC derived cell models
Jari Koistinaho, University of Helsinki, Finland
12.40–13.05 Escaping neurodegenerative diseases during the aging process: What can we learn from cognitively healthy centenarians?
Henne Holstege, Amsterdam UMC, Netherlands
13.05–13.30 Personalized medicine approaches in neurodegenerative diseases in FinnGen
Aarno Palotie, University of Helsinki, Finland
13.30–14.30 Lunch, exhibition
Oral session II: New developments in diagnostic and predictive biomarkers in neurodegenerative diseases
Time slot Session title
14.30–14.55 Emerging biofluid markers in the diagnostics of dementia
Henrik Zetterberg, University of Gothenburg, Sweden
14.55–15.20 Current and future biofluid markers in the differential diagnostics of neurodegenerative diseases
Olivia Belbin, Hospital Santa Creu i Sant Pau, Barcelona, Spain
15.20–15.45 Molecular imaging in neurodegenerative diseases
Juha Rinne, Turku PET Center, Turku, Finland
15.45–16.10 TMS as a neurophysiological tool in the early differential diagnostics of neurodegenerative diseases
Alberto Benussi, University of Brescia, Brescia, Italy
16.10–16.35 Ethical issues related to the clinical use of biomarkers in early neurodegenerative diseases
Gunhild Waldemar, University of Copenhagen, Denmark
16.35–17.15 Coffee and tea break, exhibition, and posters (even numbers)
17.15–19.15 FinFTD Network Satellite meeting
Target group: Researchers, clinicians, health care personnel, and students interested in frontotemporal dementia (FTD) and related disorders.
Chairs: Annakaisa Haapasalo and Eino Solje, University of Eastern Finland, Kuopio, Finland
17.15–17.20 Welcome and introduction
Anne Remes, University of Helsinki, Finland
17.20–17.40 Clinical early features and diagnostic challenges in FTD
Johanna Krüger, University of Oulu, Finland
17.40–18.00 Risk factors and co-morbidies of FTD
Eino Solje, University of Eastern Finland, Kuopio, Finland
18.00–18.25 Proteomic studies of FTD fluid biomarkers
Olivia Belbin, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
18.25–18.45 Disease modeling using FTD patient-derived cells
Annakaisa Haapasalo, University of Eastern Finland, Kuopio, Finland
18.45–19.10 Emerging therapeutic interventions in FTD
Alberto Benussi, University of Brescia, Brescia, Italy
19.10–19.15 Closing
Anne Remes, University of Helsinki, Finland
20.00–22.30 Get-together party
Nordic Memory Clinic Conference - NMCC: Parallel sessions I & II
Parallel session I
• NMCC Parallel session I is especially targeted for psychologists and congress participants who examine or use cognitive screening methods in their work
Neuropsychological screening test batteries to detect early cognitive changes in memory disorders:
Time slot Session title
11.05–11.25 Cognitive assessment in ethnic minority populations
Rune Nielsen, Danish Dementia Research Centre, Denmark
11.25–11.45 CERAD – the new Finnish version
Ilona Hallikainen, University of Eastern Finland, Finland
11.45–12.05 IFS and FAB screening tests in evaluation of frontal cognitive functions
Leena Heikkinen, Oulu University Hospital, Finland
12.05–12.30 Novel digital tests for early detection of cognitive impairment, new findings from Reykjavik and Kuopio studies
Jon Snaedal and Kristin Hannesdottir, National University Hospital of Iceland, Iceland and Anne Koivisto, Sanna Hannonen, and Sami Andberg, University of
Eastern Finland, Finland
Differential diagnostics of cognitive impairment in working age:
Time slot Session title
12.30–12.50 Neuropsychological assessment in burnout and stress-related illness
Hanna Malmberg-Gavelin, Umeå University, Sweden
12.50–13.10 Cognitive symptoms in working-age – diversity of etiologies
Teemu Paajanen, Finnish Institute of Occupational Health Helsinki, Finland
13.10–13.30 Cognitive aging and retirement
Linn Elena Zulka, University of Gothenburg, Sweden
Parallel session II
• NMCC Parallel session II is especially targeted for nurses and other professionals working
at memory polyclinics
Time slot Session title
14.35–15.15 Technological solutions in dementia care
Laila Oksnebjerg, Danish Dementia Research Centre
15.15–15.30 Family caregivers evaluation in memory polyclinics - should we evaluate them?
Tarja Välimäki, University of Eastern Finland, Finland
15.45–16.30 Teamwork in memory policlinics – added value for care. Experiences from Finland and Iceland
Hanna-Maria Roitto, HUS/University of Helsinki, Elli Uusikoski, Geriatric Outpatien Clinic, Helsinki City Hospital, and Jon Snaedal and a memory nurse, National
University Hospital of Iceland, Iceland
Day 3 – Thursday 25.8.2022
9th Kuopio Alzheimer Symposium
Oral session III: Co-morbidities of neurodegenerative diseases
Time slot Session title
09.00–10.30 Coffee and tea, exhibition, and posters (all numbers)
10.30–10.55 Glymphatic failure in normal pressure hydrocephalus and Alzheimer’s disease
Per Kristian Eide, Oslo University Hospital, Oslo, Norway
10.55–11.20 Intramural periarterial drainage in Alzheimer’s disease
Roxana O. Carare, University of Southampton, UK
11.20–11.45 Epilepsy in neurodegenerative disorders
Anita Kamondi, Semmelweis University, Budapest, Hungary
11.45–12.10 Herpesviruses, apolipoprotein E and Alzheimer’s disease
Ruth Itzhaki, University of Oxford, UK
12.10–12.35 Sars-Cov-2 and Alzheimer’s disease
Katja Kanninen, University of Eastern Finland, Kuopio, Finland
12.35–13.35 Lunch, exhibition
Oral session IV: New advancements in prevention and therapies of neurodegenerative diseases
Time slot Session title
13.35–14.00 WW-FINGERS updates: towards personalized prevention and global strategies
Miia Kivipelto, Karolinska Institutet, Stockholm, Sweden and University of Eastern Finland, Kuopio, Finland
14.00–14.25 Impact of COVID-19 on prevention strategies
Francesca Mangialasche, Karolinska Institutet, Stockholm, Sweden
14.25–14.50 Harmonization and data sharing in prevention studies
Markku Peltonen, THL, Helsinki, Finland
14.50–15.15 Multidomain interventions and their novel mechanisms
Tobias Hartmann, Saarland University, Homburg, Germany
15.15–15.40 The active role of citizens and patients in dementia prevention
Ana Diaz, Alzheimer Europe
15.40–16.05 EURO-FINGERS: New strategies in multidomain interventions
Wiesje van der Flier, VUMC Amsterdam, Netherlands
16.05–16.30 Coffee and tea break, exhibition, and posters (all)
Closing and award session
Time slot Session title
16.30–16.45 Best poster presentation awards
Alzheimer Research Society Finland, TBA
16.45–17.00 Closing words
Mikko Hiltunen, Miia Kivipelto
19.00–23.00 Speakers' dinner